Patients undergoing significant weight loss should discuss lean mass preservation with their GP or a registered dietitian
Ozempic mimics the effects of GLP-1, which plays a key role in regulating blood sugar and appetite
In addition to direct actions, pancreatic -cells can also be affected by paracrine actions that promote insulin production and release, thereby indirectly inhibiting glucagon secretion (Saltiel and Kahn, 2001
As a dual GIP/GLP-1 receptor agonist, it works by enhancing insulin secretion, suppressing glucagon, and slowing gastric emptying
Over time, this results in significantly reduced calorie intake and improved blood sugar controlall without the emotional stress of constant hunger or extreme dieting
these medications are a combination of GLP-1 plus gastric inhibitory polypeptide agonist (GIP) Semaglutide and tirzepatide are marketed for Type 2 diabetes and weight management under different brand names